JBT Marel (JBTM) Financials

$117.51 -1.22 (-1.03%)

As of 05/20/2025 03:59 PM Eastern

Annual Income Statements for JBT Marel

This table shows JBT Marel's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	85	583	137	119	109	129	104	81	68	56
Consolidated Net Income / (Loss)	85	583	137	119	109	129	104	81	68	56
Net Income / (Loss) Continuing Operations	85	129	104	93	109	129	104	82	68	56
Total Pre-Tax Income	95	153	120	120	146	167	129	132	94	82
Total Operating Income	118	165	133	126	163	188	144	144	101	89
Total Gross Profit	627	586	529	482	534	598	538	471	381	317
Total Revenue	1,716	1,664	1,590	1,401	1,728	1,946	1,920	1,635	1,351	1,107
Operating Revenue	1,716	1,664	1,590	1,401	1,728	1,946	1,920	1,635	1,351	1,107
Total Cost of Revenue	1,090	1,079	1,061	919	1,194	1,348	1,382	1,164	970	790
Operating Cost of Revenue	1,090	1,079	1,061	919	1,194	1,348	1,382	1,164	970	790
Total Operating Expenses	508	422	397	357	371	410	395	327	280	228
Selling, General & Admin Expense	507	410	390	351	359	396	347	325	267	207
Restructuring Charge	1.40	11	7.10	5.10	12	14	47	1.70	12	0.00
Total Other Income / (Expense), net	-23	-11	-13	-6.10	-18	-21	-14	-12	-7.00	-6.80
Interest Expense	19	24	16	11	14	19	14	14	9.40	6.80
Interest & Investment Income	24	13	3.70	3.80	-	-	-	-	-	-
Other Income / (Expense), net	-27	-	-	1.30	-3.70	-2.50	-	2.00	2.40	-
Income Tax Expense	11	24	16	27	37	38	25	50	26	26
Other Gains / (Losses), net	-0.10	-0.30	0.00	0.00	-	-	-	-	-	-
Net Income / (Loss) Discontinued Operations	0.80	453	34	27	-	-0.30	-0.30	-1.60	-0.40	-0.10
Basic Earnings per Share	$2.67	$18.21	$4.29	$3.72	$3.40	$4.04	$3.26	$2.56	$2.30	$1.89
Weighted Average Basic Shares Outstanding	32M	32M	32M	32M	32M	31.90M	31.90M	31.40M	29.40M	29.50M
Diluted Earnings per Share	$2.65	$18.13	$4.28	$3.71	$3.39	$4.02	$3.23	$2.53	$2.27	$1.88
Weighted Average Diluted Shares Outstanding	32.20M	32.10M	32.10M	32.10M	32.10M	32M	32.20M	31.90M	29.80M	29.80M
Weighted Average Basic & Diluted Shares Outstanding	51.88M	31.79M	31.81M	31.77M	31.73M	31.67M	31.52M	31.40M	29.40M	29.40M
Cash Dividends to Common per Share	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.37

This table shows JBT Marel's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-173	-7.00	39	31	23	81	442	33	27	44	34
Consolidated Net Income / (Loss)	-173	-7.00	39	31	23	81	442	33	27	44	34
Net Income / (Loss) Continuing Operations	-173	-6.90	38	31	23	53	31	28	17	27	26
Total Pre-Tax Income	-219	-11	48	27	31	59	36	37	22	30	32
Total Operating Income	-33	16	47	27	29	55	37	44	28	35	35
Total Gross Profit	293	179	164	143	140	161	145	147	133	126	136
Total Revenue	854	468	454	402	392	445	404	428	389	328	399
Operating Revenue	854	468	454	402	392	445	404	428	389	328	399
Total Cost of Revenue	562	288	290	259	252	284	259	281	256	203	263
Operating Cost of Revenue	562	288	290	259	252	284	259	281	256	203	263
Total Operating Expenses	326	164	117	116	111	106	108	103	105	91	101
Selling, General & Admin Expense	282	163	117	116	110	104	102	100	104	86	99
Research & Development Expense	34	-	-	-	-	-	-	-	-	-	-
Restructuring Charge	11	0.30	-0.20	0.20	1.10	1.70	6.40	2.50	0.80	4.30	1.50
Total Other Income / (Expense), net	-186	-26	0.80	0.60	1.80	4.20	-1.10	-7.30	-6.70	-5.10	-3.30
Interest Expense	42	8.30	4.10	4.10	2.90	3.10	5.50	8.20	7.50	8.90	3.20
Interest & Investment Income	1.40	6.40	5.90	5.70	5.70	6.70	4.60	1.10	1.00	-	-
Other Income / (Expense), net	-145	-24	-1.00	-1.00	-1.00	-	-0.20	-0.20	-0.20	-	-0.10
Income Tax Expense	-46	-3.60	9.50	-3.30	8.10	5.70	4.60	8.60	4.60	3.30	5.80
Other Gains / (Losses), net	0.00	-	0.00	0.00	-0.10	-0.20	-0.10	0.00	0.00	-	0.00
Net Income / (Loss) Discontinued Operations	0.00	-0.10	0.80	0.00	0.10	28	411	4.30	10	-	8.50
Basic Earnings per Share	($3.35)	($0.22)	$1.22	$0.96	$0.71	$2.55	$13.79	$1.02	$0.85	$1.37	$1.07
Weighted Average Basic Shares Outstanding	51.97M	32M	31.84M	31.84M	31.83M	32M	31.84M	31.84M	31.82M	32M	31.86M
Diluted Earnings per Share	($3.35)	($0.22)	$1.21	$0.95	$0.71	$2.53	$13.73	$1.02	$0.85	$1.37	$1.07
Weighted Average Diluted Shares Outstanding	51.97M	32.20M	31.84M	31.84M	31.83M	32.10M	31.84M	31.84M	31.82M	32.10M	31.86M
Weighted Average Basic & Diluted Shares Outstanding	51.97M	51.88M	31.84M	31.84M	31.83M	31.79M	31.84M	31.84M	31.82M	31.81M	31.86M
Cash Dividends to Common per Share	$0.10	-	$0.10	$0.10	$0.10	-	$0.10	$0.10	$0.10	-	$0.10

This table details how cash moves in and out of JBT Marel's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	746	376	1.40	19	8.00	-3.50	9.00	0.80	-4.00	3.90
Net Cash From Operating Activities	234	40	142	175	252	110	154	105	67	112
Net Cash From Continuing Operating Activities	233	74	135	175	252	111	155	106	68	112
Net Income / (Loss) Continuing Operations	85	129	104	93	109	129	104	82	68	56
Consolidated Net Income / (Loss)	85	583	137	119	109	129	104	81	68	56
Net Income / (Loss) Discontinued Operations	0.80	453	34	27	-	-0.30	-0.30	-1.60	-0.40	-0.10
Depreciation Expense	32	31	31	32	34	32	32	30	25	20
Amortization Expense	58	61	46	40	38	34	26	22	13	9.60
Non-Cash Adjustments To Reconcile Net Income	98	20	19	55	13	25	-10	8.40	8.20	5.90
Changes in Operating Assets and Liabilities, net	-39	-166	-64	-45	59	-109	2.70	-36	-47	21
Net Cash From Discontinued Operating Activities	1.00	-35	7.10	-	-	-0.40	-0.70	-1.70	-0.50	-0.30
Net Cash From Investing Activities	-41	729	-413	-271	-37	-402	-94	-140	-267	-185
Net Cash From Continuing Investing Activities	-41	729	-413	-271	-37	-402	-94	-140	-267	-185
Purchase of Property, Plant & Equipment	-38	-55	-85	-52	-34	-38	-40	-38	-37	-38
Acquisitions	0.00	-0.10	-330	-225	-4.50	-366	-58	-104	-232	-151
Purchase of Investments	0.00	-135	0.00	0.00	-	-	-	-	-	-
Sale of Property, Plant & Equipment	1.40	2.10	1.10	5.70	1.50	2.10	2.90	2.20	2.30	3.50
Sale and/or Maturity of Investments	0.00	125	0.00	0.00	-	-	-	-	-	-
Other Investing Activities, net	-4.80	793	0.00	-	-	-	-	-	-	-
Net Cash From Financing Activities	562	-354	271	81	-207	288	-48	35	195	84
Net Cash From Continuing Financing Activities	562	-354	271	81	-207	288	-48	35	195	84
Repayment of Debt	578	-340	293	83	-192	312	-481	-128	47	106
Repurchase of Common Equity	0.00	-5.10	-7.70	0.00	0.00	-	-20	-5.00	-4.30	-7.70
Payment of Dividends	-13	-13	-13	-13	-13	-13	-13	-13	-12	-11
Other Financing Activities, net	-3.00	4.10	-1.30	-408	-2.20	-11	-11	-11	-1.10	-3.60
Effect of Exchange Rate Changes	-9.00	-1.20	-2.50	-	0.70	0.50	-2.20	1.40	0.50	-6.80
Other Net Changes in Cash	1.00	-38	4.20	34	-	-	-	-	-	-
Cash Interest Paid	7.50	21	13	8.80	14	22	16	13	10	7.70
Cash Income Taxes Paid	33	47	28	36	36	29	20	24	26	14

This table details how cash moves in and out of JBT Marel's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1,110	647	113	-8.30	-6.00	-318	735	22	-63	28	-41
Net Cash From Operating Activities	34	130	72	22	10	-56	33	51	11	55	12
Net Cash From Continuing Operating Activities	34	129	72	22	10	-21	33	51	11	48	12
Net Income / (Loss) Continuing Operations	-173	-6.90	38	31	23	53	31	28	17	33	26
Consolidated Net Income / (Loss)	-173	-7.00	39	31	23	81	442	33	27	-	-
Net Income / (Loss) Discontinued Operations	0.00	-0.10	0.80	-	0.10	28	411	4.30	10	-	-
Depreciation Expense	61	-35	22	22	22	-39	23	24	23	-25	19
Non-Cash Adjustments To Reconcile Net Income	211	88	13	-1.90	-1.30	6.20	-17	3.90	26	4.80	-23
Changes in Operating Assets and Liabilities, net	-64	25	-1.80	-29	-33	-102	-4.60	-4.60	-55	-9.90	-9.80
Net Cash From Investing Activities	-1,766	-9.50	-9.10	-16	-7.20	117	648	-18	-17	-21	-350
Net Cash From Continuing Investing Activities	-1,766	-9.50	-9.10	-16	-7.20	117	648	-18	-17	-21	-350
Purchase of Property, Plant & Equipment	-20	-10	-6.90	-11	-11	-8.90	-11	-19	-16	-21	-21
Acquisitions	-1,746	-	-	-	0.00	-	-	1.00	-1.10	-	-329
Sale of Property, Plant & Equipment	0.60	0.50	-	0.40	0.50	0.90	0.70	0.40	0.10	0.20	0.30
Sale and/or Maturity of Investments	-0.20	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	621	585	-6.70	-10	-6.10	-8.40	-305	-11	-30	-28	308
Net Cash From Continuing Financing Activities	621	585	-6.70	-10	-6.10	-8.40	-305	-11	-30	-28	308
Repayment of Debt	-854	589	-3.50	-7.10	0.00	-0.80	-307	-7.10	-26	292	-0.30
Payment of Dividends	-5.30	-3.50	-3.20	-3.20	-3.20	-3.10	-3.30	-3.20	-3.20	-3.30	-3.10
Issuance of Debt	1,555	-	-	-	0.00	-	-0.80	-	0.20	-	312
Other Financing Activities, net	-75	-0.10	-	-	-2.90	-	5.70	-0.50	-1.10	-0.10	-
Effect of Exchange Rate Changes	0.40	-	-	-	-	-	-	-	-	-	-
Other Net Changes in Cash	0.00	-49	57	-4.10	-3.10	-369	359	-0.50	-27	26	-13

This table presents JBT Marel's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	3,414	2,710	2,641	2,141	1,806	1,915	1,443	1,391	1,187	876
Total Current Assets	1,863	1,100	927	719	616	708	619	589	485	396
Cash & Equivalents	1,228	483	72	79	48	40	43	34	33	37
Accounts Receivable	240	214	201	239	236	289	253	226	261	213
Inventories, net	233	239	264	229	197	245	206	190	140	105
Other Current Assets	162	164	141	172	135	135	116	139	52	42
Plant, Property, & Equipment, net	0.00	248	245	268	268	266	240	233	210	181
Total Noncurrent Assets	1,551	1,362	1,469	1,155	922	941	584	570	492	299
Goodwill	769	780	770	685	544	529	321	302	240	153
Intangible Assets	341	389	430	343	299	326	214	217	186	87
Other Noncurrent Operating Assets	441	194	183	128	79	86	49	38	32	28
Total Liabilities & Shareholders' Equity	3,414	2,710	2,641	2,141	1,806	1,915	1,443	1,391	1,187	876
Total Liabilities	1,870	1,222	1,736	1,391	1,169	1,345	986	950	1,008	746
Total Current Liabilities	536	484	624	550	458	475	485	441	393	353
Accounts Payable	131	135	171	186	141	199	191	157	136	111
Accrued Expenses	55	60	50	57	43	54	47	50	49	46
Current Deferred Revenue	194	172	174	190	138	107	146	128	111	116
Other Current Liabilities	155	115	112	117	134	114	101	96	91	79
Total Noncurrent Liabilities	1,334	737	1,112	841	711	871	500	508	615	393
Long-Term Debt	1,252	646	977	674	523	698	387	373	492	281
Noncurrent Employee Benefit Liabilities	19	25	32	58	94	74	73	86	86	91
Other Noncurrent Operating Liabilities	63	66	91	109	95	99	41	50	37	22
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,544	1,489	905	751	637	570	457	442	180	130
Total Preferred & Common Equity	1,544	1,489	905	751	637	570	457	442	180	130
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,544	1,489	905	751	637	570	457	442	180	130
Common Stock	235	228	221	215	230	242	246	253	78	72
Retained Earnings	1,536	1,464	894	733	628	533	417	334	267	211
Treasury Stock	-1.80	-7.10	-5.30	0.00	-1.00	-13	-19	-4.00	-7.20	-6.10
Accumulated Other Comprehensive Income / (Loss)	-225	-196	-204	-197	-220	-193	-187	-140	-157	-147

This table presents JBT Marel's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	7,999	2,789	2,690	2,691	2,689	2,588	2,580	2,555
Total Current Assets	1,489	1,206	1,125	1,102	1,092	887	866	874
Cash & Equivalents	101	535	474	479	402	43	46	53
Restricted Cash	18	-	-	-	-	-	-	-
Accounts Receivable	399	238	228	221	191	213	287	279
Inventories, net	614	259	259	250	227	237	352	347
Other Current Assets	357	174	164	153	148	144	181	196
Plant, Property, & Equipment, net	743	243	242	247	245	247	273	262
Total Noncurrent Assets	5,768	1,340	1,323	1,342	1,352	1,454	1,440	1,418
Goodwill	2,834	786	774	775	770	776	813	789
Intangible Assets	2,622	359	365	376	396	410	436	448
Other Noncurrent Operating Assets	312	196	184	190	186	183	191	182
Total Liabilities & Shareholders' Equity	7,999	2,789	2,690	2,691	2,689	2,588	2,580	2,555
Total Liabilities	3,892	1,204	1,171	1,200	1,316	1,667	1,689	1,748
Total Current Liabilities	1,183	473	443	466	584	610	618	619
Short-Term Debt	21	-	-	-	0.00	0.90	0.80	0.80
Accounts Payable	282	145	136	142	121	137	215	221
Accrued Expenses	150	45	41	33	-	-	-	-
Current Deferred Revenue	496	159	150	161	170	192	220	216
Other Current Liabilities	234	124	116	129	153	150	182	181
Total Noncurrent Liabilities	2,709	731	728	734	731	1,057	1,070	1,129
Long-Term Debt	1,966	648	648	647	646	950	957	979
Noncurrent Deferred & Payable Income Tax Liabilities	593	-	-	-	-	-	-	-
Noncurrent Employee Benefit Liabilities	16	22	22	23	18	29	31	44
Other Noncurrent Operating Liabilities	133	60	59	63	67	66	82	106
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,107	1,585	1,519	1,491	1,373	921	891	806
Total Preferred & Common Equity	4,107	1,585	1,519	1,491	1,373	921	891	806
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,107	1,585	1,519	1,491	1,373	921	891	806
Common Stock	2,728	232	228	226	224	222	221	218
Retained Earnings	1,358	1,546	1,511	1,483	1,366	902	874	817
Treasury Stock	0.00	-2.10	-2.20	-3.20	-2.10	-2.20	-3.70	-0.40
Accumulated Other Comprehensive Income / (Loss)	22	-191	-218	-214	-215	-200	-200	-229

This table displays calculated financial ratios and metrics derived from JBT Marel's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.10%	4.66%	13.53%	-18.93%	-11.20%	1.35%	17.41%	21.07%	21.96%	12.51%
EBITDA Growth	-29.49%	22.61%	4.92%	-13.93%	-8.00%	24.71%	2.03%	39.18%	19.65%	56.05%
EBIT Growth	-44.69%	24.21%	4.49%	-20.39%	-14.16%	29.14%	-1.37%	41.01%	16.18%	75.54%
NOPAT Growth	-24.60%	21.55%	17.98%	-20.28%	-16.35%	25.28%	30.32%	22.23%	20.50%	73.56%
Net Income Growth	-85.34%	324.02%	15.37%	9.47%	-15.66%	23.92%	29.32%	19.08%	20.93%	81.49%
EPS Growth	-85.38%	323.60%	15.36%	9.44%	-15.67%	24.46%	27.67%	11.45%	20.74%	82.52%
Operating Cash Flow Growth	489.90%	-72.17%	-18.64%	-30.60%	128.68%	-28.40%	47.13%	55.19%	-39.77%	44.02%
Free Cash Flow Firm Growth	114.49%	162.06%	-7.46%	-156.78%	183.95%	-366.00%	287.92%	71.38%	-267.14%	-1,364.01%
Invested Capital Growth	-5.26%	3.10%	19.25%	20.78%	-9.33%	53.36%	1.31%	22.58%	71.97%	43.79%
Revenue Q/Q Growth	1.36%	7.51%	23.08%	-22.61%	-5.79%	0.42%	2.87%	5.06%	3.89%	5.63%
EBITDA Q/Q Growth	-1.20%	35.59%	63.25%	-3.54%	7.29%	13.76%	17.22%	23.82%	12.26%	16.85%
EBIT Q/Q Growth	-41.11%	14.14%	36.14%	-24.96%	-10.50%	0.54%	4.96%	18.15%	3.30%	10.97%
NOPAT Q/Q Growth	-24.16%	15.91%	28.44%	-21.60%	-10.51%	0.78%	29.25%	-3.73%	2.08%	10.54%
Net Income Q/Q Growth	-50.78%	6.76%	9.48%	1.88%	-9.93%	-0.62%	29.16%	-4.39%	3.36%	11.35%
EPS Q/Q Growth	-50.93%	6.84%	9.18%	1.92%	-10.08%	-0.25%	29.20%	-6.64%	3.18%	11.90%
Operating Cash Flow Q/Q Growth	183.15%	-72.46%	44.32%	-31.20%	6.60%	-32.31%	145.85%	-3.68%	-25.85%	46.47%
Free Cash Flow Firm Q/Q Growth	382.32%	-75.21%	57.75%	-596.76%	6.52%	-28.06%	1,714.30%	79.59%	-412.82%	-772.74%
Invested Capital Q/Q Growth	-7.71%	10.91%	-7.40%	3.36%	-3.84%	-1.26%	-8.93%	-0.60%	51.22%	18.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.51%	35.19%	33.29%	34.42%	30.89%	30.74%	28.00%	28.79%	28.19%	28.62%
EBITDA Margin	10.52%	15.38%	13.13%	14.21%	13.38%	12.92%	10.50%	12.08%	10.51%	10.71%
Operating Margin	6.90%	9.90%	8.34%	8.97%	9.44%	9.67%	7.49%	8.79%	7.48%	8.04%
EBIT Margin	5.31%	9.90%	8.34%	9.06%	9.23%	9.54%	7.49%	8.92%	7.66%	8.04%
Profit (Net Income) Margin	4.98%	35.00%	8.64%	8.50%	6.30%	6.63%	5.42%	4.92%	5.01%	5.05%
Tax Burden Percent	89.52%	380.54%	114.50%	99.67%	74.78%	77.29%	80.70%	60.89%	71.91%	68.00%
Interest Burden Percent	104.72%	92.96%	90.50%	94.17%	91.28%	89.88%	89.71%	90.67%	90.91%	92.36%
Effective Tax Rate	11.22%	15.35%	13.50%	22.59%	25.22%	22.53%	19.07%	37.90%	27.66%	31.87%
Return on Invested Capital (ROIC)	6.52%	8.55%	7.77%	7.90%	10.41%	14.36%	14.61%	12.43%	14.32%	19.06%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.26%	110.92%	11.28%	11.98%	8.09%	11.01%	11.08%	10.27%	12.78%	16.61%
Return on Net Nonoperating Assets (RNNOA)	-0.89%	40.11%	8.82%	9.26%	7.63%	10.78%	8.55%	13.46%	29.35%	25.86%
Return on Equity (ROE)	5.63%	48.67%	16.60%	17.17%	18.03%	25.14%	23.16%	25.89%	43.67%	44.92%
Cash Return on Invested Capital (CROIC)	11.93%	5.50%	-9.79%	-10.92%	20.20%	-27.76%	13.31%	-7.85%	-38.61%	-16.87%
Operating Return on Assets (OROA)	2.98%	6.16%	5.55%	6.43%	8.57%	11.06%	10.15%	11.31%	10.02%	11.31%
Return on Assets (ROA)	2.79%	21.77%	5.75%	6.03%	5.85%	7.68%	7.35%	6.24%	6.55%	7.10%
Return on Common Equity (ROCE)	5.63%	48.67%	16.60%	17.17%	18.03%	25.14%	23.16%	25.89%	43.67%	44.92%
Return on Equity Simple (ROE_SIMPLE)	5.53%	39.13%	15.18%	15.87%	17.08%	22.65%	22.78%	18.22%	37.58%	43.10%
Net Operating Profit after Tax (NOPAT)	105	139	115	97	122	146	116	89	73	61
NOPAT Margin	6.13%	8.38%	7.21%	6.94%	7.06%	7.49%	6.06%	5.46%	5.41%	5.48%
Net Nonoperating Expense Percent (NNEP)	20.78%	-102.36%	-3.50%	-4.08%	2.31%	3.35%	3.54%	2.16%	1.54%	2.44%
Return On Investment Capital (ROIC_SIMPLE)	3.76%	6.53%	6.09%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	63.49%	64.81%	66.71%	65.58%	69.11%	69.26%	72.00%	71.21%	71.81%	71.38%
SG&A Expenses to Revenue	29.53%	24.61%	24.50%	25.09%	20.75%	20.37%	18.07%	19.89%	19.80%	18.69%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.64%
Operating Expenses to Revenue	29.61%	25.34%	24.95%	25.45%	21.45%	21.07%	20.56%	19.99%	20.71%	20.58%
Earnings before Interest and Taxes (EBIT)	91	165	133	127	159	186	144	146	103	89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	181	256	209	199	231	251	202	198	142	119
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.62	2.12	3.19	6.43	5.60	6.15	4.86	7.71	13.52	10.80
Price to Tangible Book Value (P/TBV)	9.32	9.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.36	1.89	1.82	3.45	2.06	1.80	1.16	2.08	1.80	1.26
Price to Earnings (P/E)	47.39	5.41	21.02	40.53	32.76	27.17	21.34	42.34	35.97	25.05
Dividend Yield	0.31%	0.40%	0.44%	0.26%	0.36%	0.36%	0.57%	0.37%	0.48%	0.77%
Earnings Yield	2.11%	18.47%	4.76%	2.47%	3.05%	3.68%	4.69%	2.36%	2.78%	3.99%
Enterprise Value to Invested Capital (EV/IC)	2.60	2.00	2.36	4.03	3.63	3.39	3.20	4.75	4.49	4.39
Enterprise Value to Revenue (EV/Rev)	2.37	1.99	2.39	3.87	2.34	2.14	1.34	2.30	2.15	1.49
Enterprise Value to EBITDA (EV/EBITDA)	22.55	12.96	18.17	27.25	17.48	16.57	12.74	19.03	20.42	13.88
Enterprise Value to EBIT (EV/EBIT)	44.69	20.14	28.61	42.73	25.36	22.43	17.85	25.77	28.02	18.49
Enterprise Value to NOPAT (EV/NOPAT)	38.73	23.79	33.07	55.77	33.14	28.57	22.05	42.08	39.65	27.14
Enterprise Value to Operating Cash Flow (EV/OCF)	17.43	83.76	26.66	31.00	16.04	37.79	16.67	35.93	42.98	14.71
Enterprise Value to Free Cash Flow (EV/FCFF)	21.18	37.01	0.00	0.00	17.08	0.00	24.21	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.81	0.43	1.08	0.90	0.82	1.23	0.85	0.87	2.77	2.18
Long-Term Debt to Equity	0.81	0.43	1.08	0.90	0.82	1.23	0.85	0.84	2.73	2.16
Financial Leverage	0.06	0.36	0.78	0.77	0.94	0.98	0.77	1.31	2.30	1.56
Leverage Ratio	2.02	2.24	2.89	2.84	3.08	3.27	3.15	4.15	6.67	6.32
Compound Leverage Factor	2.11	2.08	2.61	2.68	2.81	2.94	2.83	3.76	6.06	5.84
Debt to Total Capital	44.78%	30.27%	51.92%	47.33%	45.17%	55.11%	45.90%	46.44%	73.49%	68.56%
Short-Term Debt to Total Capital	0.00%	0.00%	0.03%	0.00%	0.21%	0.07%	0.06%	1.27%	1.05%	0.53%
Long-Term Debt to Total Capital	44.78%	30.27%	51.89%	47.33%	44.97%	55.04%	45.84%	45.17%	72.44%	68.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	55.22%	69.73%	48.08%	52.67%	54.83%	44.89%	54.10%	53.56%	26.51%	31.44%
Debt to EBITDA	6.94	2.53	4.68	3.39	2.27	2.78	1.92	1.94	3.51	2.38
Net Debt to EBITDA	0.13	0.64	4.34	2.99	2.06	2.63	1.71	1.77	3.28	2.07
Long-Term Debt to EBITDA	6.94	2.53	4.68	3.39	2.26	2.78	1.92	1.89	3.46	2.37
Debt to NOPAT	11.91	4.64	8.53	6.94	4.30	4.80	3.33	4.29	6.83	4.66
Net Debt to NOPAT	0.23	1.17	7.90	6.13	3.91	4.52	2.96	3.91	6.37	4.05
Long-Term Debt to NOPAT	11.91	4.64	8.52	6.94	4.28	4.79	3.33	4.17	6.73	4.63
Altman Z-Score	2.99	3.39	2.38	3.51	3.67	3.44	3.53	4.14	3.28	3.12
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.48	2.27	1.48	1.31	1.35	1.49	1.27	1.33	1.23	1.12
Quick Ratio	2.74	1.44	0.44	0.58	0.62	0.69	0.61	0.59	0.75	0.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	192	90	-144	-134	237	-282	106	-56	-197	-54
Operating Cash Flow to CapEx	640.00%	74.72%	170.42%	380.22%	768.29%	307.82%	417.07%	293.00%	193.68%	327.19%
Free Cash Flow to Firm to Interest Expense	9.91	3.69	-8.86	-12.00	17.03	-14.99	7.62	-4.15	-20.96	-7.89
Operating Cash Flow to Interest Expense	12.04	1.63	8.73	15.62	18.13	5.86	11.07	7.69	7.17	16.46
Operating Cash Flow Less CapEx to Interest Expense	10.16	-0.55	3.61	11.51	15.77	3.96	8.42	5.07	3.47	11.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.62	0.67	0.71	0.93	1.16	1.35	1.27	1.31	1.41
Accounts Receivable Turnover	7.56	8.02	7.24	5.90	6.58	7.18	8.01	6.72	5.71	5.70
Inventory Turnover	4.62	4.29	4.30	4.31	5.40	5.97	6.98	7.06	7.93	7.29
Fixed Asset Turnover	0.00	6.75	6.20	5.23	6.48	7.70	8.12	7.38	6.90	6.74
Accounts Payable Turnover	8.20	7.07	5.95	5.62	7.04	6.91	7.94	7.95	7.87	7.90
Days Sales Outstanding (DSO)	48.29	45.49	50.45	61.91	55.45	50.87	45.56	54.28	63.92	64.06
Days Inventory Outstanding (DIO)	79.06	85.08	84.82	84.70	67.60	61.09	52.33	51.69	46.01	50.04
Days Payable Outstanding (DPO)	44.49	51.64	61.34	64.90	51.86	52.79	45.99	45.89	46.37	46.23
Cash Conversion Cycle (CCC)	82.87	78.94	73.93	81.72	71.20	59.17	51.89	60.08	63.56	67.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,568	1,655	1,605	1,346	1,115	1,229	802	791	645	375
Invested Capital Turnover	1.06	1.02	1.08	1.14	1.47	1.92	2.41	2.28	2.65	3.48
Increase / (Decrease) in Invested Capital	-87	50	259	232	-115	428	10	146	270	114
Enterprise Value (EV)	4,071	3,317	3,794	5,422	4,042	4,165	2,566	3,758	2,897	1,646
Market Capitalization	4,047	3,154	2,887	4,827	3,565	3,505	2,222	3,409	2,431	1,400
Book Value per Share	$48.49	$46.76	$28.42	$23.62	$20.08	$17.98	$14.46	$14.00	$6.17	$4.45
Tangible Book Value per Share	$13.64	$10.07	($9.25)	($8.72)	($6.49)	($9.01)	($2.48)	($2.43)	($8.42)	($3.76)
Total Capital	2,796	2,135	1,883	1,425	1,162	1,269	845	825	679	413
Total Debt	1,252	646	978	674	525	699	388	383	499	283
Total Long-Term Debt	1,252	646	977	674	523	698	387	373	492	281
Net Debt	24	163	906	596	477	660	345	349	466	246
Capital Expenditures (CapEx)	37	53	84	46	33	36	37	36	35	34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	99	133	231	90	114	195	91	124	66	8.10
Debt-free Net Working Capital (DFNWC)	1,328	616	303	169	161	235	134	158	99	45
Net Working Capital (NWC)	1,328	616	303	169	159	234	133	147	92	43
Net Nonoperating Expense (NNE)	20	-443	-23	-22	13	17	12	8.80	5.46	4.73
Net Nonoperating Obligations (NNO)	24	166	700	596	477	660	345	349	466	246
Total Depreciation and Amortization (D&A)	89	91	76	72	72	66	58	52	39	30
Debt-free, Cash-free Net Working Capital to Revenue	5.79%	7.96%	14.55%	6.42%	6.57%	10.03%	4.72%	7.57%	4.88%	0.73%
Debt-free Net Working Capital to Revenue	77.38%	37.00%	19.06%	12.05%	9.32%	12.06%	6.96%	9.64%	7.34%	4.09%
Net Working Capital to Revenue	77.38%	37.00%	19.02%	12.05%	9.18%	12.01%	6.94%	9.00%	6.81%	3.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.67	$18.21	$4.08	$3.70	$3.40	$4.04	$3.26	$2.56	$2.30	$1.89
Adjusted Weighted Average Basic Shares Outstanding	32M	32M	32M	32M	32M	31.90M	31.90M	31.40M	29.40M	29.50M
Adjusted Diluted Earnings per Share	$2.65	$18.13	$4.07	$3.69	$3.39	$4.02	$3.23	$2.53	$2.27	$1.88
Adjusted Weighted Average Diluted Shares Outstanding	32.20M	32.10M	32.10M	32.10M	32.10M	32M	32.20M	31.90M	29.80M	29.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	51.88M	31.79M	31.81M	31.77M	31.73M	31.67M	31.52M	31.58M	29.32M	29.24M
Normalized Net Operating Profit after Tax (NOPAT)	106	149	121	101	131	156	154	90	82	61
Normalized NOPAT Margin	6.20%	8.96%	7.60%	7.22%	7.58%	8.03%	8.04%	5.53%	6.07%	5.48%
Pre Tax Income Margin	5.56%	9.20%	7.55%	8.53%	8.42%	8.58%	6.72%	8.09%	6.96%	7.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.70	6.78	8.14	11.33	11.47	9.88	10.35	10.72	11.00	13.09
NOPAT to Interest Expense	5.42	5.74	7.04	8.68	8.77	7.76	8.37	6.57	7.77	8.92
EBIT Less CapEx to Interest Expense	2.81	4.60	3.01	7.22	9.11	7.97	7.69	8.10	7.30	8.06
NOPAT Less CapEx to Interest Expense	3.54	3.56	1.91	4.57	6.41	5.85	5.72	3.94	4.07	3.89
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.34%	2.20%	9.53%	10.75%	11.76%	9.85%	12.58%	15.78%	17.46%	20.04%
Augmented Payout Ratio	15.34%	3.07%	15.14%	10.75%	11.76%	9.85%	31.80%	21.99%	23.82%	33.81%

This table displays calculated financial ratios and metrics derived from JBT Marel's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	117.72%	5.17%	12.44%	-5.94%	0.98%	35.42%	1.20%	8.55%	-17.20%	990.70%	-16.46%
EBITDA Growth	-334.26%	-362.05%	13.71%	-28.99%	-1.38%	59.62%	11.78%	38.81%	0.79%	141.77%	-11.42%
EBIT Growth	-734.16%	-115.61%	24.80%	-41.50%	-0.35%	56.53%	5.76%	37.81%	-7.84%	0.00%	-14.11%
NOPAT Growth	-208.89%	-77.91%	16.48%	-11.69%	-4.06%	58.71%	13.27%	23.63%	-18.58%	0.00%	-8.36%
Net Income Growth	-858.77%	-108.63%	-91.19%	-6.12%	-16.18%	83.48%	1,191.23%	-2.10%	6.25%	36.84%	16.72%
EPS Growth	-571.83%	-108.70%	-91.19%	-6.86%	-16.47%	84.67%	1,183.18%	-1.92%	6.25%	35.64%	17.58%
Operating Cash Flow Growth	237.25%	331.61%	117.88%	-57.81%	-8.77%	-201.27%	175.00%	42.62%	-70.84%	376.72%	-63.64%
Free Cash Flow Firm Growth	-2,730.80%	164,801.30%	-161.91%	87.27%	140.16%	99.97%	167.88%	15.63%	-59.53%	1.66%	-258.55%
Invested Capital Growth	260.18%	-5.26%	13.85%	3.44%	-7.96%	3.10%	-13.91%	17.16%	31.63%	19.25%	33.10%
Revenue Q/Q Growth	82.66%	3.04%	12.80%	2.55%	-11.76%	10.16%	-5.63%	10.09%	18.34%	-17.68%	1.22%
EBITDA Q/Q Growth	-170.34%	-163.97%	41.67%	-4.38%	186.86%	-72.24%	-11.54%	32.81%	384.76%	-80.56%	9.86%
EBIT Q/Q Growth	-1,972.09%	-118.78%	77.52%	-8.19%	-49.82%	50.14%	-16.78%	56.38%	-20.11%	1.44%	8.44%
NOPAT Q/Q Growth	-312.74%	-70.66%	24.75%	39.85%	-57.36%	54.67%	-5.42%	51.94%	-28.59%	10.38%	3.23%
Net Income Q/Q Growth	-2,371.43%	-117.99%	26.71%	34.65%	-58.62%	-81.64%	1,250.46%	20.22%	-38.46%	29.24%	2.40%
EPS Q/Q Growth	-1,422.73%	-118.18%	27.37%	33.80%	-58.72%	-81.57%	1,246.08%	20.00%	-37.96%	28.04%	2.88%
Operating Cash Flow Q/Q Growth	-73.48%	80.39%	232.87%	107.69%	148.60%	-269.70%	-35.55%	349.12%	-76.35%	360.83%	-66.57%
Free Cash Flow Firm Q/Q Growth	-4,524.59%	157.96%	-546.64%	-115.86%	4,543.25%	-100.02%	232.96%	49.95%	-80.37%	43.44%	-65.25%
Invested Capital Q/Q Growth	281.13%	-7.71%	0.40%	1.99%	0.43%	10.91%	-8.78%	-9.25%	12.30%	-7.40%	24.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.25%	38.37%	36.05%	35.60%	35.76%	36.17%	35.88%	34.42%	34.21%	38.29%	33.98%
EBITDA Margin	-13.77%	-9.30%	14.98%	11.93%	12.80%	3.73%	14.82%	15.81%	13.10%	3.17%	13.42%
Operating Margin	-3.91%	3.36%	10.31%	6.66%	7.42%	12.39%	9.14%	10.36%	7.31%	10.72%	8.73%
EBIT Margin	-20.86%	-1.84%	10.09%	6.41%	7.16%	12.39%	9.09%	10.31%	7.26%	10.72%	8.70%
Profit (Net Income) Margin	-20.26%	-1.50%	8.57%	7.63%	5.81%	18.24%	109.42%	7.65%	7.00%	13.46%	8.58%
Tax Burden Percent	78.92%	66.67%	81.72%	112.04%	73.79%	138.40%	1,233.52%	88.38%	125.35%	146.84%	108.57%
Interest Burden Percent	123.01%	122.09%	103.93%	106.20%	109.96%	106.35%	97.55%	83.90%	76.95%	85.51%	90.78%
Effective Tax Rate	0.00%	0.00%	19.96%	-12.04%	26.21%	9.73%	12.85%	23.24%	21.20%	10.96%	18.41%
Return on Invested Capital (ROIC)	-1.56%	2.50%	8.76%	7.37%	5.28%	11.42%	7.65%	8.09%	5.48%	10.29%	6.06%
ROIC Less NNEP Spread (ROIC-NNEP)	-16.26%	-16.45%	10.00%	7.52%	5.52%	18.67%	85.91%	7.90%	6.13%	12.27%	6.82%
Return on Net Nonoperating Assets (RNNOA)	-5.91%	-1.03%	0.79%	2.74%	2.50%	6.75%	41.25%	6.10%	5.48%	9.60%	6.86%
Return on Equity (ROE)	-7.47%	1.47%	9.55%	10.11%	7.78%	18.17%	48.90%	14.19%	10.96%	19.89%	12.92%
Cash Return on Invested Capital (CROIC)	-112.05%	11.93%	-4.27%	4.63%	16.26%	5.50%	22.41%	-8.14%	-20.39%	-9.79%	-22.52%
Operating Return on Assets (OROA)	-8.50%	-1.03%	6.24%	3.99%	4.53%	7.71%	5.37%	6.62%	4.58%	7.13%	4.90%
Return on Assets (ROA)	-8.25%	-0.84%	5.30%	4.75%	3.68%	11.35%	64.61%	4.91%	4.41%	8.95%	4.83%
Return on Common Equity (ROCE)	-7.47%	1.47%	9.55%	10.11%	7.78%	18.17%	48.90%	14.19%	10.96%	19.89%	12.92%
Return on Equity Simple (ROE_SIMPLE)	-2.69%	0.00%	10.95%	37.94%	38.78%	0.00%	39.74%	15.01%	15.60%	0.00%	15.57%
Net Operating Profit after Tax (NOPAT)	-23	11	37	30	21	50	32	34	22	31	28
NOPAT Margin	-2.74%	2.35%	8.25%	7.46%	5.47%	11.19%	7.97%	7.95%	5.76%	9.55%	7.12%
Net Nonoperating Expense Percent (NNEP)	14.69%	18.96%	-1.24%	-0.15%	-0.25%	-7.24%	-78.26%	0.20%	-0.64%	-1.99%	-0.76%
Return On Investment Capital (ROIC_SIMPLE)	-0.38%	0.39%	-	-	-	2.33%	-	-	-	1.66%	-
Cost of Revenue to Revenue	65.75%	61.63%	63.95%	64.40%	64.24%	63.83%	64.12%	65.58%	65.79%	61.71%	66.02%
SG&A Expenses to Revenue	32.98%	34.94%	25.78%	28.88%	28.07%	23.39%	25.15%	23.47%	26.69%	26.26%	24.87%
R&D to Revenue	3.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.16%	35.01%	25.74%	28.93%	28.35%	23.93%	26.73%	24.06%	26.90%	27.57%	25.25%
Earnings before Interest and Taxes (EBIT)	-178	-8.60	46	26	28	55	37	44	28	35	35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-118	-44	68	48	50	17	60	68	51	10	54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.54	2.62	1.98	1.99	2.23	2.12	2.43	4.17	3.88	3.19	3.37
Price to Tangible Book Value (P/TBV)	0.00	9.32	7.12	7.95	9.80	9.84	16.11	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.91	2.36	1.85	1.84	2.00	1.89	2.15	2.49	2.29	1.82	2.10
Price to Earnings (P/E)	0.00	47.39	18.08	5.24	5.76	5.41	6.11	27.77	24.86	21.02	21.66
Dividend Yield	0.33%	0.31%	0.41%	0.42%	0.38%	0.40%	0.38%	0.33%	0.37%	0.44%	0.47%
Earnings Yield	0.00%	2.11%	5.53%	19.08%	17.35%	18.47%	16.37%	3.60%	4.02%	4.76%	4.62%
Enterprise Value to Invested Capital (EV/IC)	1.37	2.60	1.91	1.89	2.11	2.00	2.31	2.90	2.42	2.36	2.10
Enterprise Value to Revenue (EV/Rev)	3.77	2.37	1.92	1.94	2.10	1.99	2.23	3.08	2.89	2.39	2.82
Enterprise Value to EBITDA (EV/EBITDA)	0.00	22.55	17.79	18.30	18.03	12.96	18.29	26.02	26.69	18.17	28.50
Enterprise Value to EBIT (EV/EBIT)	0.00	44.69	21.01	21.93	21.36	20.14	23.93	33.37	33.54	28.61	37.43
Enterprise Value to NOPAT (EV/NOPAT)	209.77	38.73	23.45	23.96	25.39	23.79	28.71	40.85	39.78	33.07	40.82
Enterprise Value to Operating Cash Flow (EV/OCF)	31.84	17.43	39.40	73.23	47.82	83.76	24.01	38.67	40.62	26.66	36.97
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	21.18	0.00	41.43	12.44	37.01	9.55	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.81	0.41	0.43	0.43	0.43	0.47	1.03	1.07	1.08	1.22
Long-Term Debt to Equity	0.48	0.81	0.41	0.43	0.43	0.43	0.47	1.03	1.07	1.08	1.21
Financial Leverage	0.36	0.06	0.08	0.36	0.45	0.36	0.48	0.77	0.89	0.78	1.01
Leverage Ratio	1.91	2.02	1.85	2.16	2.21	2.24	2.41	2.81	2.86	2.89	3.03
Compound Leverage Factor	2.35	2.47	1.92	2.30	2.43	2.38	2.35	2.36	2.20	2.47	2.75
Debt to Total Capital	32.61%	44.78%	29.03%	29.89%	30.26%	30.27%	31.99%	50.78%	51.79%	51.92%	54.86%
Short-Term Debt to Total Capital	0.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.05%	0.04%	0.03%	0.04%
Long-Term Debt to Total Capital	32.26%	44.78%	29.03%	29.89%	30.26%	30.27%	31.99%	50.73%	51.75%	51.89%	54.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.39%	55.22%	70.97%	70.11%	69.74%	69.73%	68.01%	49.22%	48.21%	48.08%	45.14%
Debt to EBITDA	-44.07	6.94	3.55	3.71	3.33	2.53	3.42	5.21	5.85	4.68	7.66
Net Debt to EBITDA	-41.43	0.13	0.62	0.99	0.87	0.64	0.63	4.97	5.57	4.34	7.25
Long-Term Debt to EBITDA	-43.59	6.94	3.55	3.71	3.33	2.53	3.42	5.20	5.85	4.68	7.65
Debt to NOPAT	50.79	11.91	4.68	4.86	4.69	4.64	5.37	8.18	8.72	8.53	10.97
Net Debt to NOPAT	47.75	0.23	0.82	1.30	1.22	1.17	0.99	7.81	8.30	7.90	10.38
Long-Term Debt to NOPAT	50.25	11.91	4.68	4.86	4.69	4.64	5.37	8.17	8.71	8.52	10.96
Altman Z-Score	1.46	2.89	3.32	3.28	3.38	3.26	3.08	2.65	2.44	2.26	2.05
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.26	3.48	2.55	2.54	2.37	2.27	1.87	1.45	1.40	1.48	1.41
Quick Ratio	0.42	2.74	1.63	1.59	1.50	1.44	1.23	0.42	0.54	0.44	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,340	98	-169	-26	165	-0.06	273	-206	-411	-228	-403
Operating Cash Flow to CapEx	177.32%	1,365.26%	1,042.03%	213.86%	104.00%	-700.00%	323.53%	275.27%	70.37%	262.09%	59.11%
Free Cash Flow to Firm to Interest Expense	-102.36	11.82	-41.28	-6.38	56.89	-0.02	49.70	-25.07	-54.78	-25.59	-125.85
Operating Cash Flow to Interest Expense	0.81	15.63	17.54	5.27	3.59	-18.06	6.00	6.24	1.52	6.21	3.75
Operating Cash Flow Less CapEx to Interest Expense	0.35	14.48	15.85	2.80	0.14	-20.65	4.15	3.98	-0.64	3.84	-2.59
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.56	0.62	0.62	0.63	0.62	0.59	0.64	0.63	0.67	0.56
Accounts Receivable Turnover	7.03	7.56	7.90	7.44	6.57	8.02	6.60	6.41	5.76	7.24	5.10
Inventory Turnover	3.24	4.62	4.47	4.25	3.57	4.29	3.48	3.74	3.15	4.30	2.95
Fixed Asset Turnover	4.40	0.00	6.93	6.72	6.42	6.75	6.10	6.05	5.57	6.20	4.87
Accounts Payable Turnover	6.59	8.20	8.16	7.72	6.01	7.07	5.83	5.56	4.61	5.95	4.11
Days Sales Outstanding (DSO)	51.96	48.29	46.19	49.07	55.59	45.49	55.32	56.96	63.38	50.45	71.51
Days Inventory Outstanding (DIO)	112.66	79.06	81.69	85.89	102.21	85.08	104.93	97.62	116.05	84.82	123.88
Days Payable Outstanding (DPO)	55.39	44.49	44.74	47.28	60.72	51.64	62.63	65.62	79.12	61.34	88.72
Cash Conversion Cycle (CCC)	109.23	82.87	83.14	87.67	97.07	78.94	97.62	88.96	100.32	73.93	106.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,976	1,568	1,699	1,692	1,659	1,655	1,492	1,636	1,803	1,605	1,733
Invested Capital Turnover	0.57	1.06	1.06	0.99	0.96	1.02	0.96	1.02	0.95	1.08	0.85
Increase / (Decrease) in Invested Capital	4,317	-87	207	56	-144	50	-241	240	433	259	431
Enterprise Value (EV)	8,208	4,071	3,250	3,193	3,500	3,317	3,453	4,748	4,367	3,794	3,645
Market Capitalization	6,340	4,047	3,137	3,020	3,332	3,154	3,334	3,841	3,455	2,887	2,718
Book Value per Share	$79.17	$48.49	$49.78	$47.71	$46.84	$46.76	$43.13	$28.95	$28.01	$28.42	$25.30
Tangible Book Value per Share	($26.00)	$13.64	$13.83	$11.93	$10.68	$10.07	$6.50	($8.33)	($11.28)	($9.25)	($13.49)
Total Capital	6,095	2,796	2,233	2,166	2,138	2,135	2,019	1,872	1,848	1,883	1,786
Total Debt	1,988	1,252	648	648	647	646	646	951	957	978	980
Total Long-Term Debt	1,966	1,252	648	648	647	646	646	950	957	977	979
Net Debt	1,869	24	114	173	168	163	119	908	912	906	927
Capital Expenditures (CapEx)	19	9.50	6.90	10	10	8.00	10	19	16	21	20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	208	99	198	208	157	133	-19	235	203	231	203
Debt-free Net Working Capital (DFNWC)	327	1,328	732	683	636	616	507	278	249	303	256
Net Working Capital (NWC)	305	1,328	732	683	636	616	507	277	248	303	255
Net Nonoperating Expense (NNE)	150	18	-1.44	-0.67	-1.33	-31	-409	1.30	-4.82	-13	-5.81
Net Nonoperating Obligations (NNO)	1,869	24	114	173	168	166	119	715	912	700	927
Total Depreciation and Amortization (D&A)	61	-35	22	22	22	-39	23	24	23	-25	19
Debt-free, Cash-free Net Working Capital to Revenue	9.53%	5.79%	11.68%	12.67%	9.43%	7.96%	-1.25%	15.22%	13.45%	14.55%	15.74%
Debt-free Net Working Capital to Revenue	14.99%	77.38%	43.25%	41.54%	38.14%	37.00%	32.77%	17.99%	16.47%	19.06%	19.81%
Net Working Capital to Revenue	14.01%	77.38%	43.25%	41.54%	38.14%	37.00%	32.77%	17.94%	16.42%	19.02%	19.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.35)	($0.22)	$1.22	$0.96	$0.71	$2.55	$14.60	$0.97	$0.80	$1.37	$1.07
Adjusted Weighted Average Basic Shares Outstanding	51.97M	32M	31.84M	31.84M	31.83M	32M	31.84M	31.84M	31.82M	32M	31.86M
Adjusted Diluted Earnings per Share	($3.35)	($0.22)	$1.21	$0.95	$0.71	$2.53	$14.54	$0.97	$0.80	$1.37	$1.07
Adjusted Weighted Average Diluted Shares Outstanding	51.97M	32.20M	31.84M	31.84M	31.83M	32.10M	31.84M	31.84M	31.82M	32.10M	31.86M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	51.97M	51.88M	31.84M	31.84M	31.83M	31.79M	31.84M	31.84M	31.82M	31.81M	31.86M
Normalized Net Operating Profit after Tax (NOPAT)	-16	11	37	19	22	51	38	36	23	35	30
Normalized NOPAT Margin	-1.87%	2.40%	8.22%	4.70%	5.68%	11.53%	9.35%	8.40%	5.92%	10.71%	7.43%
Pre Tax Income Margin	-25.66%	-2.25%	10.49%	6.81%	7.88%	13.18%	8.87%	8.65%	5.59%	9.17%	7.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.20	-1.04	11.17	6.29	9.69	17.77	6.67	5.38	3.76	3.96	10.84
NOPAT to Interest Expense	-0.55	1.32	9.14	7.32	7.40	16.05	5.85	4.15	2.98	3.52	8.87
EBIT Less CapEx to Interest Expense	-4.66	-2.18	9.49	3.83	6.24	15.19	4.82	3.11	1.60	1.58	4.50
NOPAT Less CapEx to Interest Expense	-1.01	0.18	7.45	4.86	3.96	13.46	3.99	1.88	0.82	1.15	2.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-13.77%	15.34%	7.32%	2.22%	2.21%	2.20%	2.38%	9.26%	9.42%	9.53%	10.44%
Augmented Payout Ratio	-13.77%	15.34%	7.32%	2.22%	2.21%	3.07%	2.38%	9.26%	9.42%	15.14%	12.67%

Frequently Asked Questions About JBT Marel's Financials

When does JBT Marel's fiscal year end?

According to the most recent income statement we have on file, JBT Marel's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has JBT Marel's net income changed over the last 9 years?

JBT Marel's net income appears to be on an upward trend, with a most recent value of $85.40 million in 2024, rising from $55.90 million in 2015. The previous period was $582.60 million in 2023. View JBT Marel's forecast to see where analysts expect JBT Marel to go next.

What is JBT Marel's operating income?

JBT Marel's total operating income in 2024 was $118.40 million, based on the following breakdown:

Total Gross Profit: $626.50 million
Total Operating Expenses: $508.10 million

How has JBT Marel revenue changed over the last 9 years?

Over the last 9 years, JBT Marel's total revenue changed from $1.11 billion in 2015 to $1.72 billion in 2024, a change of 55.0%.

How much debt does JBT Marel have?

JBT Marel's total liabilities were at $1.87 billion at the end of 2024, a 53.1% increase from 2023, and a 150.5% increase since 2015.

How much cash does JBT Marel have?

In the past 9 years, JBT Marel's cash and equivalents has ranged from $33.20 million in 2016 to $1.23 billion in 2024, and is currently $1.23 billion as of their latest financial filing in 2024.

How has JBT Marel's book value per share changed over the last 9 years?

Over the last 9 years, JBT Marel's book value per share changed from 4.45 in 2015 to 48.49 in 2024, a change of 989.5%.

Related Companies

This page (NYSE:JBTM) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

JBT Marel (JBTM) Financials

Frequently Asked Questions About JBT Marel's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

JBT Marel (JBTM) Financials

Annual Income Statements for JBT Marel

Quarterly Income Statements for JBT Marel

Annual Cash Flow Statements for JBT Marel

Quarterly Cash Flow Statements for JBT Marel

Annual Balance Sheets for JBT Marel

Quarterly Balance Sheets for JBT Marel

Annual Metrics And Ratios for JBT Marel

Quarterly Metrics And Ratios for JBT Marel

Frequently Asked Questions About JBT Marel's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools